Developer
StudioVR Games: Revenue & Sales Estimates
Est. catalog lifetime net (USD): $87.4KRevenue estimates for the 6 Steam games developed by StudioVR, ranked by estimated net revenue. Available estimated lifetime net (USD): $87.4K.
Catalog Est. Lifetime Net (USD)
$87.4K
Estimates for 4 of 6 tracked games
Tracked games
6
Top Earner
Dungeon Desire: The Sleepless City of Runeheim
$24.5K
Coverage: 6 tracked titles; 4 with net estimates; 2 without. 0 have dedicated profiles. Missing estimates are excluded from the aggregate, not treated as known zero revenue.
Role: Developer. These are lifetime estimates for games credited to StudioVR; they are not company earnings, profit, or contractual receipts. Credits may omit co-development or historical publishing arrangements. Developer and publisher identities are not merged by matching names.
Recorded release dates: 2024-09-20–2025-12-12 (may include announced dates).
Largest title accounts for 28.0% of available estimated net revenue. Coverage gaps can change this share.
Showing 1–6 of the top 6 displayed entries, from 6 tracked titles. Figures include only available estimates. Search the full catalog .
Rows 1–6 · Page 1 of 1
| # | Game | Est. lifetime net (USD) | Positive reviews (raw) | Release |
|---|---|---|---|---|
| 1 | Dungeon Desire: The Sleepless City of Runeheim | $24.5K | 82%Positive (82) | Feb 7, 2025 |
| 2 | The Lustful Inn of Female Adventurers | $22.8K | 86%Positive (99) | Jul 18, 2025 |
| 3 | Until Chloe, the New Wife, Falls | $20.7K | 75%Positive (81) | Sep 20, 2024 |
| 4 | I Wish I Had Never Gone into the Dungeon | $19.4K | 88%Positive (91) | Dec 12, 2025 |
| 5 | UndercoVR | — | (0) | — |
| 6 | Succubus Survivors | — | (0) | — |
Get real-time dashboards, historical trends, and AI-powered analysis
Explore on PlayRev(opens in new tab)Revenue and sales estimates are based on the Boxleiter method using publicly available data including Steam review counts, pricing history, and statistical modeling. Actual revenue may differ significantly. These figures are provided for informational purposes only and should not be used for financial decisions. Read the full methodology.